Champions Oncology Inc
CSBR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$66.95M
Close$
$0.08
98.3% downside
Current Fair Value
98.3% downsideOvervalued by 98.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $66.95 Million |
|---|---|
| Enterprise Value | $92.55 Million |
| Earnings per Share | $-0.08 |
| Beta | 0.44 |
| Outstanding Shares | 13,897,535 |
Return
| Return on Equity | -29.15% |
|---|---|
| Return on Assets | -3.41% |
| Return on Invested Capital | -10.35% |
Valuation & Multiples
| P/E Ratio | -60.89 |
|---|---|
| PEG | 709.32 |
| Price to Sales | 1.64 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.1 |
| Enterprise Value to EBIT | -61.41 |
| Enterprise Value to Net Income | -82 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 7.7 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 16, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$15.04 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 15, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$16.37 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 42.58% |
|---|---|
| Total Invested | $50▼ 100.00% |
| Investors Holding | 1▼ 26.00% |
About Champions Oncology Inc
143 employees
Champions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computa...